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Background: The diabetes epidemic in China imposes an increasing burden on the health 
care system and the economy. We derived prospective diabetes prevalence rates in China until 
2016 from a systematic review of the published literature in the period 1987–2007. The results 
could help to guide resources of the Chinese health care system in order to address the diabetes 
epidemic.
Methods: We selected articles published in the English/Chinese languages from MEDLINE 
and the China Wanfang Digital Database using the keywords “China”, “diabetes mellitus”, 
“prevalence”, and “epidemiology” in order to estimate the current diabetes prevalence in China. 
For projecting future prevalence rates, we considered the population growth, and assumed 
that China’s diabetes prevalence in first tier cities in 2016 would equal Hong Kong’s diabetes 
prevalence in 2007.
Results: The number of Chinese adults with diabetes is projected to rise from 53.1 million 
in 2009 to 76.1 million in 2016. The estimated diabetes prevalence rate in China in 2009 was 
3.9% (urban 5.2%, rural 2.9%) and is projected to increase to 5.4% (urban 6.9%, rural 3.8%) 
in 2016, corresponding to an annual consolidated aggregate growth rate of 4.6%.
Conclusion: We estimate a considerably higher diabetes prevalence in the adult Chinese 
population than that reported in previous studies. The diabetes prevalence will continue to rise 
in the future, which points to the importance of increasing awareness and better diagnosis of 
diabetes in China.
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Introduction
Diabetes increases the risk of developing long-term microvascular and macrovascular 
complications and represents a major public health concern.1 The World Health Orga-
nization (WHO) estimates that more than 180 million people worldwide suffered from 
diabetes in 2008, a number which will be more than twice as high by 2030.2 Prevalence 
estimates of diabetes and impaired glucose tolerance in all Asian countries, adjusted to 
those for the world population, are high and are expected to increase further.3 China has 
one of the largest single diabetes populations worldwide, due to rapid westernization, 
with its associated changes in dietary habits and a sedentary lifestyle.4 Diabetes and its 
complications also have significant economic consequences for individuals, families, 
and health care systems. The WHO estimates that from 2006 to 2015 China will lose 
$558 billion of its national income due to heart disease, stroke, and diabetes.2 There-
fore, adequate financial resources and structures of health care delivery are required 
to deal with the future diabetes burden, particularly in the context of continued rapid International Journal of General Medicine  2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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urbanization.5 Previous nationwide epidemiologic studies, 
conducted between 1997 and 2006, showed diabetes preva-
lence rates varying between 0.6%–6.8%.6–11 However, these 
studies were cross-sectional in nature and were carried out in 
different cities at various time points. Furthermore, estima-
tion of future diabetes prevalence will allow us to understand 
and address better the diabetes burden in China. We carried 
out a systematic literature review of the published data for 
diabetes prevalence in China and tried to estimate prevalence 
rates of diabetes for the years 2009–2016 for the urban and 
rural populations.
Methodology
Search strategy
We conducted a systematic literature search of MEDLINE 
and the China Wanfang Digital Database12 for articles 
containing the keywords “China”, “diabetes mellitus”, 
“prevalence”, and “epidemiology”, published in the English 
or Chinese language for 1987–2007. Titles and abstracts of 
the resulting publications were screened for further articles 
that were possibly of interest for our review. The references 
in the relevant articles and review articles were checked for 
additional studies of interest. We included original articles 
of observational studies on diabetes prevalence for China 
published in peer-reviewed journals. We excluded random-
ized controlled trials, editorials, letters to the editor, and 
review articles.
Data extraction
The key parameter of interest was the prevalence of diabetes. 
On initial screening, articles were selected if they reported 
prevalence data on diabetes. The full texts of relevant articles 
were scrutinized, and the extracted data on coverage, study 
population, age group, year of study, and results (original/
age-standardized prevalence rates) were organized in tables. 
The definitions and diagnostic measures used to define dia-
betes prevalence varied across studies. The population-based 
studies from China used the 1997 criteria from the American 
Diabetes Association (ADA) or the 1999 criteria from WHO 
to diagnose diabetes.6–9 In the present study, we selected pub-
lications using the WHO/ADA criteria for diabetes diagnosis 
(ie, fasting plasma glucose .7.0 mmol/L).
estimation of diabetes prevalence
Estimates of the nationwide diabetes prevalence rate 
were derived from major diabetes epidemiologic surveys 
in China,6,7,9,11,13 and are summarized in Table 1. Table 2 
presents prevalence rates as measured in studies of various 
Chinese populations.5,6,14–30 Differences in prevalence rates 
are most likely to be due to different survey methodologies, 
diagnostic criteria, time points of analyses, and the cities 
where the studies were conducted. Based on a database 
of 661 Chinese cities, the urban population was classified 
into four city tiers according to wealth distribution (Gross 
Domestic Product per capita) and population.31 The catego-
rization into urban and rural segments was based on the 
definition provided in the China Statistics Yearbook.32 Since 
the patients’ ages differed significantly, the crude overall 
prevalence rates were corrected for age (see Table 3). We 
used the 2000 China National Census data for standardizing 
prevalence. For first tier cities, we selected a standard-
ized prevalence of 7.6% from the most recently published 
report.15 For other city tiers, we calculated the prevalence 
rate for 2009 by taking an average of the age-standardized 
Table 1 Major nationwide surveys on diabetes prevalence in China
Reference Sample  Sample size  Age (years) Year of study Prevalence   
(%)
Southern Research Institute  
of Medicine economics DM  
prevalence survey, 200411
Nationwide NA All 1978 
1990 
1995 
2000
0.6 
1.2 
1.5 
2.4
Pan et al6 19 provinces,  
urban and rural
224,251 25–64 1994 2.5
Yang et al7 12 areas 
12 urban areas  
12 rural areas
29,559 40–99 1998 5.9 
6.8 
3.8
Gu et al9 Nationwide 15,540 35–74 2000 5.5
Li et al13 Nationwide 
Urban 
Rural
NA 18 2002 2.6 
4.5 
1.8
Abbreviation: NA, not available.International Journal of General Medicine  2010:3 submit your manuscript | www.dovepress.com
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prevalence rates (fifth column in Table 3). This approach 
was confirmed to be reasonable by diabetes experts in 
China. We adjusted the average age-standardized preva-
lence rate by the difference between percentage of the adult 
population (.19 years) in 2000 (67.9%) and 2009 (72.3%) 
to calculate the prevalence rate in 2009 (eighth column 
in Table 3).33 We projected a prevalence rate increase for 
each forecast year thereafter (2010–2016) based on the 
trends suggested by the   available data and assumptions for 
prevalence growth rate (Table 4). For first tier cities, we 
assumed that the 2016 diabetes   prevalence in China would 
equal the 2007 diabetes prevalence in Hong Kong, where 
the population had the earliest exposure to risk factors for 
diabetes, in particular, a more sedentary lifestyle and a 
high-fat diet, but is of the same ethnic origin as the popula-
tion in mainland China. The annual growth rate of diabetes 
Table 2 Studies on diabetes prevalence in China by city/province
Reference Tier Region Sample  
size
Age  
(years)
Year of  
survey
Prevalence  
(%)
Age-standardized   
prevalencea (%)
City level 
Pan et al6 1 Beijing – .25 1994 4.5 3.2
Pan et al14 1 Beijing 29,859 30–64 1995 – 3.6
Jia et al15 1 Beijing 2706 .18 2005 – 7.6
Zhu et al16 1 Beijing – .15 2006 7.7 –
Pan et al5 1 Guangzhou 775 .20 2002 6.6 4.4
Sheng et al17 1 Shanghai – .30 1998 3.7 4.8
Li et al18 1 Shanghai 11,589 .15 2005 8.6 6.2
Hu et al19 2 Chengdu 1445 20–74 2004 4.6 3.3
Hu et al20 2 Hangzhou – .15 2001 6.9 4.9
Dong et al21 2 Qingdao 2634 20–74 2004 – 10.0
Luo et al22 2 Changsha 5124 25–80 1994 6.1 5.4
Huang et al23 3 Nantong 36,849 .20 2006 4.8 3.4
Zhong et al24 4 Ganzhou 2908 .18 2006 4.4 3.1
Feng et al25 4 Jinzhong 3000 .20 2006 4.2 3.2
Tan et al26 4 Shaoyang 786 .20 2005 4.5 3.2
Province level
Sun et al27 Urban and rural Hebei 5892 .25 2002 5.8 –
Zhang et al28 Urban and rural Sichuan 4641 .3 2002 2.2 2.6
Hu et al20 Urban and rural Zhejiang 7417 .35 2002 5.9 –
Li et al29 Urban and rural Jilin 1649 All 2005 3.5 2.5
Ma et al30 Urban and rural Qinghai 2276 20–74 2003 3.1 2.2
Urban Qinghai urban – – 2003 4.5 4.7
Rural Qinghai rural – – 2003 1.5 1.0
Notes: aAge-standardized prevalence of diabetes was calculated if not reported in published study.
Table 3 estimation of baseline prevalence rate for 2009 based on analysis of available data
City Year of  
survey
Age-standardized  
prevalence (%)
Average of  
age-standardized  
prevalence (%)
Total population  
in 2009 (million)
Number of people  
with diabetes in  
2009 (million)
Prevalence  
rate in 2009   
(%)
Urban – – – – 596.945 31.410 5.2
Tier 1 Beijing 2005 7.6 7.6 32.756 2.735 8.3
Tier 2 Chengdu 2004 3.3 6.1 154.282 10.410 6.7
Hangzho 2006 4.9
Qingdao 2004 10.0
Tier 3 Nantong 2005 5.4 5.4 113.857 6.903 6.0
Tier 4 Ganzhao 2006 3.4 3.2 296.050 11.362 3.8
Jinzhong 2004 3.1
Shaoyang 2006 3.2
Rural – – – 2.7a 748.264 21.679 2.9
Total – – – – 1345.209 53.089 3.9
Notes: aPrevalence rate for rural area was assumed to be 80% of fourth tier prevalence rate in 2009.International Journal of General Medicine  2010:3 submit your manuscript | www.dovepress.com
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  prevalence was described as the consolidated aggregate 
growth rate (CAGR) from 2009–2016, and was calculated 
as the ending value/beginning value/number of years.
Results
The literature search yielded 70 potentially relevant papers. 
Of these, 27 epidemiologic studies on diabetes prevalence 
rate in China were included, ie, five national studies with a 
large patient population and representative of entire China 
(Table 1) and 22 provincial/city level (Table 2) studies. Of 
the total Chinese population (1345 million), approximately 
597 million resided in urban areas, while 748 million people 
resided in rural areas in 2009 (Figure 1). The estimated dia-
betes prevalence rates in China were 3.9% (urban 5.2%, rural 
2.9%) in 2009 and were estimated to increase to 5.4% (urban 
6.9%, rural 3.8%) in 2016. Accordingly, the total number 
of people suffering from diabetes is projected to rise from 
53.1 million in 2009 to 76.1 million in 2016. From 2009 to 
2016, the urban population is projected to increase more 
than the rural population (1.6-fold versus 1.2-fold). From 
2009 to 2016, the number of diabetes cases in urban areas 
will increase from 31.4 million (59%) to 49.3 million (65%), 
while in rural areas it will increase from 21.7 million (41%) 
to 26.8 million (35%). The prevalent population, prevalence 
rates, and CAGR for all the four tiers are presented in Table 3. 
The CAGR calculated from 2009 to 2016 was 4.6%, describ-
ing the rate at which prevalence might grow, if it grew at a 
steady rate. The prevalence increase in the urban, rural, and 
total Chinese population by year is presented in Figure 2.
Discussion
We estimate the number of adult patients with diabetes in 
China to have been approximately 53.1 million in 2009 and 
that it will increase to about 76.1 million in 2016, with an 
annual growth rate of 4.6%. These numbers are much higher 
than the previous estimates of 39.8 million adult patients with 
diabetes in 2007 and 59.3 million in 2025.34 Because we used 
the same total population size as reported in previous papers 
Table 4 Projections for the increase in prevalence rate in 2016 based on assumptions
Age- 
standardized  
prevalence rate in  
2009 (%)
Total population  
size in 2016  
(million)
Assumptions Number of  
people with  
diabetes in  
2016 (million)
Growth  
(%/year)  
2009–2016
Prevalence   
rate in  
2016 (%)
Urban 5.2 704.917 – 49.318 4.1 6.9
Tier 1 8.3 38,751 By 2016, the  
prevalence rate of  
tier 1 cities will  
reach the 2007  
prevalence rate in  
Hong Kong
3.790 2.3 9.8
Tier 2 6.7 182,518 By 2016, the  
prevalence rate of  
tier 2 cities will reach  
90% of the 2007  
prevalence rate in  
tier 1 cities
15.008 2.9 8.2
Tier 3 6.0 134,695 By 2016, the  
prevalence rate of  
tier 3 cities will reach  
the 2007 prevalence  
rate in tier 2 cities
9.902 2.8 7.3
Tier 4 3.8 350,231 By 2016, the  
prevalence rate of  
tier 4 cities will reach  
90% of the 2007  
prevalence rate in  
tier 3 cities
20.618 6.3 5.8
Rural 2.9 701,624 By 2016, the  
prevalence rate of  
rural area will reach  
the 2007 prevalence  
rate in tier 4 cities
26.766 4.0 3.8
Total 3.9 1406.541 – 76.084 4.6 5.4International Journal of General Medicine  2010:3 submit your manuscript | www.dovepress.com
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for calculating 2009 and 2016 prevalence, demographic 
changes cannot account completely for the difference in 
estimated prevalence. However, the higher prevalence can 
potentially be explained by the inclusion of recent studies that 
reported a higher prevalence of diabetes, or has less stringent 
inclusion criteria (eg, studies considering only fasting plasma 
glucose .7.0 mmol/L) for diagnosis of diabetes. However, 
our data are confirmed by more recent data provided by the 
International Diabetes Federation.47
The present study shows that the prevalence of diabetes 
in China in 2009 is higher in urban areas (5.2%, 31.4 million 
people) than in rural areas (2.9%, 21.6 million people). 
In the urban population, the projected diabetes prevalence 
in first tier cities increased from 2.7 million (8.3%) to 
3.7 million (9.8%), while that in fourth tier cities increased 
from 11.3 million (3.8%) to 20.6 million people (5.8%). 
These findings are in agreement with those of previous 
  epidemiologic studies conducted in China.7–9,16,35 Further-
China
1345.209 million 
Rural
748.264 million 
Urban
596.945 million 
661 cities 
Tier 1 
32.756 million 
3 cities 
(eg, Beijing) 
Tier 2 
154.282 million 
60 cities 
(eg, Shenzhen, 
Ningbo) 
Tier 3 
113.857 million 
110 cities 
(eg,
Lianyungang)
Tier 4 
296.050 million 
488 cities 
(eg, Tonglin, 
Yulin)
Figure 1 Flow chart of the distribution of Chinese population in 2009.
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more, our findings also underscore the increasing importance 
of obesity as the strongest risk factor for the development 
of diabetes in China, which in turn is caused by excessive 
consumption of high-calorie food and declining physical 
activity, a phenomenon which is particularly evident in urban 
communities.36–39 The present study reported an estimated 
prevalence rate of 3.9% in 2009, which is comparable with an 
earlier reported prevalence rate of 3.9% for China in 2007.40 
An earlier study showed that the diabetes prevalence rate 
in China is lower than that in Hong Kong and Singapore, 
where estimated rates are 9%–12%.38,41 Hong Kong, being 
one of the most cosmopolitan cities in the world, can be 
considered as the demographic prototype of China in the 
future.42 Rapid changes in lifestyle, such as an increasingly 
high-fat diet, physical inactivity, and psychosocial stress 
might unmask a genetic predisposition of some individuals 
to develop   diabetes.43 Therefore, based on trends suggested 
by the available data, we predict that the diabetes prevalence 
rate in first tier Chinese cities will reach the level of Hong 
Kong’s 2007 prevalence by 2016. Although the present 
study suggests a high diabetes prevalence in China, our data 
likely still underestimates the real burden of diabetes, since 
many diabetic patients are undiagnosed or are diagnosed 
late.44,45 Our findings are in agreement with data from other 
large Asian countries. India, which is undergoing the same 
development as China, is facing an even higher and rapidly 
increasing burden of diabetes, with an estimated 50 million 
people suffering from diabetes today, and projected to 
increase to 87 million people by 2030.47 Thus, in the light of 
the expected high prevalence of diabetes in 2016, rigorous 
efforts are required to improve on prevention strategies and 
diagnosis of diabetes by putting in place effective public 
health policies. This would be important in light of the fact 
that Type 2 diabetes can be delayed or even prevented by 
lifestyle counseling or drug therapy in the primary care 
setting.46
The strength of our study is that that we analyzed data 
published during the past two decades, in both English and 
Chinese languages, representing adult populations from 
all over China, including rural and urban populations. The 
limitations of our study are that the prevalence of diabetes 
was based solely on the growth in Chinese population, no 
modifications were made for possible increases in age-
specific prevalence over time, and we searched the selected 
papers from 1987 to 2007, hence more recent publications 
were not included in the analysis.
Taken together, our results predict a constant rise in 
the prevalence of diabetes in China from 2009 to 2016, 
at an annual growth rate of 4%–5%. The much higher 
current diabetes burden in China than that observed in 
earlier studies represents a serious concern for the Chi-
nese health care system. Even though there are national 
education programs on diabetes in China (eg, Project 
HOPE), our findings point to the necessity for develop-
ing further strategies for diabetes prevention, awareness, 
and early diagnosis of the disease, in order to reduce the 
economic and societal burden of the disease and its long-
term complications.
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